HCW Biologics
NASDAQ: HCWBMiramar, US · Founded 2018 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
HC
Hing C WongExecutive Officer, Director
LF
Lee FlowersExecutive Officer
RB
Rebecca ByamExecutive Officer
PR
Peter RhodeExecutive Officer
PS
Peter SunDirector
FM
Fred M. MiddletonDirector
NV
Nicole ValdiviesoExecutive Officer
HC
Hing C. WongExecutive Officer, Director
GW
Gary WinerDirector
RS
Rick S. GreeneDirector
LM
Lisa M. GilesDirector
ST
Scott T. GarrettDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.6MraisedAug 2026 · 4 investors · BiotechnologyRule 506(b)
▶$1.6MraisedAug 2026 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hing C. WongExecutive Officer, Director
- Rebecca ByamExecutive Officer
- Peter RhodeExecutive Officer
- Scott T. GarrettDirector
- Rick S. GreeneDirector
- Lisa M. GilesDirector
- Lee FlowersExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJun 2026 · 7 investors · BiotechnologyRule 506(b)
▶$4MraisedJun 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
- Scott T. GarrettDirector
- Lee FlowerExecutive Officer
- Peter RhodeExecutive Officer
- Lisa M. GilesDirector
- Hing C. WongExecutive Officer, Director
- Rick S. GreeneDirector
- Rebecca ByamExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedDec 2024 · 1 investors · BiotechnologyRule 506(b)
▶$6.9MraisedDec 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lee FlowersExecutive Officer
- Gary WinerDirector
- Rick S. GreeneDirector
- Rebecca ByamExecutive Officer
- Lisa M. GilesDirector
- Scott T. GarrettDirector
- Hing C WongExecutive Officer, Director
- Peter RhodeExecutive Officer
- Offering amount
- $6.9M
- Amount sold
- $6.9M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedFeb 2024 · 6 investors · BiotechnologyRule 506(b)
▶$2.5MraisedFeb 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hing C. WongExecutive Officer, Director
- Rick S. GreeneDirector
- Peter RhodeExecutive Officer
- Lisa M. GilesDirector
- Gary WinerDirector
- Scott T. GarrettDirector
- Lee FlowersExecutive Officer
- Rebecca ByamExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedOct 2020 · 9 investors · BiotechnologyRule 506(b)
▶$6.2MraisedOct 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hing C WongExecutive Officer, Director
- Peter SunDirector
- Fred M. MiddletonDirector
- Rebecca ByamExecutive Officer
- Peter RhodeExecutive Officer
- Nicole ValdiviesoExecutive Officer
- Offering amount
- $16M
- Amount sold
- $6.2M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- HCW Biologics Raises $1.6 Million in Private Placement; Units Priced at $2.585 — TradingView Newstradingview.com · 2026
- HCW Biologics Announces Pricing of $1.6 Million Private Placement Offering | Quiver Quantitativequiverquant.com · 2026
- Biotech HCW Biologics plans $4M share sale to fund trials and cut debtstocktitan.net · 2026
- HCW Biologics Raises $4M in Private Placement Financing - TipRanks.comtipranks.com · 2026